临床研究
ENGLISH ABSTRACT
建立液相色谱-串联质谱检测血浆游离变肾上腺素和去甲变肾上腺素诊断嗜铬细胞瘤的临床策略
黄斐
陈方俊
彭颖斐
吴炯
郭玮
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1001-9030.2017.11.053
Establishment a diagnostic strategy of pheochromocytoma by plasma free metanephrines determined by liquid chromatography-tandem mass spectrometry
Huang Fei
Chen Fangjun
Peng Yingfei
Wu Jiong
Guo Wei
Authors Info & Affiliations
Huang Fei
Department of Clinical Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Chen Fangjun
Peng Yingfei
Wu Jiong
Guo Wei
·
DOI: 10.3760/cma.j.issn.1001-9030.2017.11.053
315
28
0
0
1
0
PDF下载
APP内阅读
摘要

目的建立液相色谱-串联质谱(LC-MS/MS)平台检测血浆游离变肾上腺素(MN)和去甲变肾上腺素(NMN)诊断嗜铬细胞瘤的临床策略。

方法招募255例健康人以建立参考范围。另招募于复旦大学附属中山医院泌尿外科和内分泌科就诊患者,嗜铬细胞瘤组110例、疾病对照组1 262例和健康对照组500例,比较各组间MN和NMN水平。依据参考范围和由受试者工作特征曲线(ROC)得到最佳特异性切点制定诊断策略。

结果MN和NMN参考范围分别为<64.97 pg/ml和<185.83 pg/ml。嗜铬细胞瘤组MN和NMN水平显著高于疾病对照组( Z=-17.410, P=0.000; Z=-17.278, P=0.000)和健康对照组( Z=-16.434, P=0.000; Z=-16.439, P=0.000)。定义MN和NMN中任意一个超过参考范围上限为诊断策略A,MN和NMN中任意一个指标超过特异性诊断切点为诊断策略B,用于排除和辅助诊断嗜铬细胞瘤。

结论建立LC-MS/MS平台检测MN和NMN的参考范围,为临床提供嗜铬细胞瘤的诊断策略。

液相色谱-串联质谱法;变肾上腺素;去甲变肾上腺素;嗜铬细胞瘤
ABSTRACT

ObjectiveTo set up reference intervals of plasma free metanephrine (MN) and normetanephrine (NMN) by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and diagnostic strategies of pheochromocytoma.

Methods255 healthy people were recruited to set up reference intervals.110 patients with pheochromocytoma were also enrolled, in addition to 1 262 subjects taken as disease control group and 500 subjects taken as health control group. Positive rates of plasma free MN and NMN were compared among different groups. Diagnostic strategies were designed according to reference intervals and cut-off value with optimal specificity determined by receiver operating characteristic (ROC) curve.

ResultsThe reference intervals of MN and NMN are <64.97 pg/ml and <185.83 pg/ml, respectively. Significant differences in the level of MN and NMN were found between not only pheochromocytoma group and disease control group ( Z=-17.410, P=0.000; Z=-17.278, P=0.000), but also pheochromocytoma group and health control group ( Z=-16.434, P=0.000; Z=-16.439, P=0.000). We establish diagnostic strategy A for either of MN and NMN above the upper limit of the reference range and B for either of MN and NMN above specific diagnostic cutoff value to rule in or rule out the diagnosis of pheochromocytoma.

ConclusionThe reference intervals of plasma free MN and NMN by LC-MS/MS and diagnostic strategies of pheochromocytoma.

Liquid chromatography-tandem mass spectrometry;Metanephrine;Normetanephrine;Pheochromocytoma
Guo Wei, Email: nc.defhsab.latipsoh-sziew.oug
The State Key Laboratory of Clinical College Construction Project; The National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAI37B01); National Natural Science Foundation of China (81572064); Key Developing Disciplines of Shanghai Municipal Commission of Health and Family Planning (2015ZB0201)
引用本文

黄斐,陈方俊,彭颖斐,等. 建立液相色谱-串联质谱检测血浆游离变肾上腺素和去甲变肾上腺素诊断嗜铬细胞瘤的临床策略[J]. 中华实验外科杂志,2017,34(11):1982-1984.

DOI:10.3760/cma.j.issn.1001-9030.2017.11.053

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
嗜铬细胞瘤是一种神经内分泌肿瘤,大多源于肾上腺髓质,而少数源于肾上腺外的嗜铬细胞。由于肿瘤引起阵发或持续性儿茶酚胺(CA)的分泌 [ 1 ],易导致患者血压异常以及代谢紊乱。部分患者因长期高血压致严重的心、脑、肾损害或高血压危象,因此及早发现、诊断和治疗嗜铬细胞瘤能避免上述情况发生。
传统辅助诊断嗜铬细胞瘤的生化指标包括血CA和尿CA、尿香草扁桃酸等,但缺乏敏感性和特异性。最新研究结果显示,相较于其他生物指标,变肾上腺素(MN)和去甲变肾上腺素(NMN)对嗜铬细胞瘤的辅助诊断具有较高价值 [ 2 ]。血浆游离MN和NMN的半衰期较CA长,因此其诊断性能更加稳定,可直接反映肿瘤细胞状态 [ 3 ]。为此,血浆游离MN和NMN逐渐成为嗜铬细胞瘤诊治指导中推荐的标志物 [ 4 ]。我们在对自建液相色谱-串联质谱(LC-MS/MS)平台行完整性能验证的基础上 [ 5 ],进行后续研究以建立该平台检测MN和NMN的参考范围,为临床提供嗜铬细胞瘤的诊断策略。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Manger WM , Gifford RW . Pheochromocytoma[J]J Clin Hypertens 20024(1):62-72. DOI: 10.1111/j.1524-6175.2002.01452 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Hickman PE , Leong M , Chang J et al. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma[J]Pathology 200941(2):173-177. DOI: 10.1080/00313020802579284 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Eisenhofer G , Huynh TT , Hiroi M et al. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma[J]RevEndocr Metab Disord 20012(3):297-311. DOI: 10.1023/A:1011572617314 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Pacak K , Eisenhofer G , Ahlman H et al. Pheochromocytoma:recommendations for clinical practice from the First International Symposium.October 2005[J]Nat Clin Pract Endocrinol Metab 20073(2):92-102. DOI: 10.1038/ncpendmet0396 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
陈方俊吴炯郭玮液相色谱-串联质谱检测血浆变肾上腺素和去甲变肾上腺素方法的建立[J]中华检验医学杂志 201538(9):605-608.
返回引文位置Google Scholar
百度学术
万方数据
Chen FJ , Wu J , Guo W et al. Development of a LC-MS/MS method for the simultaneous determination of metanephrine and norepinephrine in human plasma[J]Chin J Lab Med 201538(9):605-608. DOI: 10.3760/cma.j.issn.1009-9158.2015.09.009 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[6]
Manger WM . An overview of pheochromocytoma:history,current concepts vagaries,and diagnostic challenges[J]Ann N Y Acad Sci 20061073:1-20. DOI: 10.1196/annals.1353.001 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Eisenhofer G , Goldstein DS , Walther MM et al. Biochemical diagnosis of pheochromocytoma:how to distinguish true-from false-positive test results[J]J Clin Endocrinol Metab 200388(6):2656-2666. DOI: 10.1210/jc.2002-030005 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Lenders JW , Pacak K , Eisenhofer G New advancesin the biochemical diagnosis of pheochromocytoma:moving beyond catecholamines[J]Ann N Y Acad Sci 2002970:29-40. DOI: 10.1111/j.1749-6632.2002.tb04410 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Lenders JW , Pacak K , Walther MM et al. Biochemical diagnosis of pheochromocytoma:which test is best[J]JAMA 2002287(11):1427-1434. DOI: 10.1001/jama.287.11.1427 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
郭玮,Email: nc.defhsab.latipsoh-sziew.oug
B
"十二五"国家科技支撑计划 (2012BAI37B01)
国家自然科学基金面上项目 (81572064)
上海市卫生计生系统重要薄弱学科建设项目 (2015ZB0201)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号